Gilad Shabtai Net Worth & Insider Trades

Gilad Shabtai Eloxx Pharmaceuticals, Inc

As of May 1, 2018

What is Gilad Shabtai's Net Worth?

The current estimated net worth of Eloxx Pharmaceuticals, Inc's Gilad Shabtai is estimated to be about $1.04M . Gilad Shabtai owns about 3,351,770 units of Eloxx Pharmaceuticals, Inc common stock. In the last month at Eloxx Pharmaceuticals, Inc, Gilad Shabtai has sold an estimated value of $0 worth.

What is Gilad Shabtai's Past Insider Trading?

Gilad Shabtai's largest purchase order was 75,000 units , worth over $731.25K on May 1, 2018. In total, Gilad Shabtai has made about 3 transactions over a month of their time at Eloxx Pharmaceuticals, Inc. Gilad Shabtai usually trades in April, with the busiest year in 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Gilad Shabtai's' Mailing Address?

  • Mailing address is Unit 2706 Michelangelo Towers 8 Maude Street Sandton T3 2416 South Africa

Eloxx Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert E. Ward 2020 $83,333 - - - - $499,237 $582,570
Robert E. Ward 2019 $500,000 - - $1,771,840 $200,000 $47,408 $2,519,248
Gregory C. Williams 2020 $454,583 - $718,000 $916,000 $142,500 $13,798 $2,254,881
Neil S. Belloff, Esq. 2020 $411,525 - $359,000 $458,000 $100,800 $105,579 $1,434,904
Neil S. Belloff, Esq. 2019 $367,138 - $288,250 $825,000 $147,660 $46,178 $1,674,226
Stephen G. MacDonald 2020 $276,250 - - $63,198 $67,320 $24,766 $431,534
Stephen G. MacDonald 2019 $50,469 $15,000 - $39,750 - $2,516 $107,735
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1035354/000110465921045562/tm212576-1_def14a.htm

What are Eloxx Pharmaceuticals, Inc's Past Insider Trades?

Eloxx Pharmaceuticals, Inc's most recent insider trade came on December 1, 2021 by Daniel E Geffken who bought 50,000 units worth $36K . In the last 3 years, insiders at Eloxx Pharmaceuticals, Inc have sold an estimated value of $1.75M and bought an estimated value of $47.3M worth of shares. Insider trading is most common in May, with the busiest year in 2018 and 2021. The most active traders at the company are Neil S Belloff, COO,  Gregory Williams, CHIEF EXECUTIVE OFFICER,  and Ran Nussbaum, Director .

Eloxx Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1